Resonac Holdings has made strategic moves by carving out its petrochemical arm as a standalone entity, Crasus Chemical, in preparation for an upcoming split. Similarly, GSK has entered into a licensing agreement with UK-based Touchlight to utilize their doggybone DNA technology for the development of mRNA vaccines targeting seasonal epidemics and pandemic threats. SK Innovation from South Korea plans to merge with SK E&S, reuniting both firms that were originally part of the same company. Indorama Ventures is set to spin off Indovinya in 2026 after acquiring businesses from Huntsman and Oxiteno. On the innovation front, Messer Group is set to construct a 10 MW green hydrogen plant in Germany to produce hydrogen primarily for fuel cell buses. Kurita America is collaborating with Solugen to create carbon-negative industrial water-treatment products, utilizing Solugen's innovative chemienzymatic process. Additionally, Eurofins CDMO Alphora has expanded its drug active manufacturing facility in Ontario, while AcceleDev Chemical has opened a new R&D and production facility in New Jersey. These developments signify a positive trend of growth, innovation, and collaboration within the chemical industry.